Cargando…
Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
Extramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383523/ https://www.ncbi.nlm.nih.gov/pubmed/34434362 http://dx.doi.org/10.14740/jmc3428 |
_version_ | 1783741755039940608 |
---|---|
author | Alkan, Onur Tiryaki, Tarik Onur Kalayoglu-Besisik, Sevgi |
author_facet | Alkan, Onur Tiryaki, Tarik Onur Kalayoglu-Besisik, Sevgi |
author_sort | Alkan, Onur |
collection | PubMed |
description | Extramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagnosis of MPE was confirmed by the detection of myeloma cells in the pleural fluid using flow cytometric analyses. We present a case of a 67-year-old male patient with IgG-kappa myelom. After a few line treatment regimens, he was admitted to hospital with back pain and blurred consciousness, and pleural effusion was detected. Pleural fluid analysis showed malignant plasma cells. It is a rare presentation of multiple myeloma, but important in diagnosis. |
format | Online Article Text |
id | pubmed-8383523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83835232021-08-24 Myelomatous Pleural Effusion: A Rare Involvement in Myeloma Alkan, Onur Tiryaki, Tarik Onur Kalayoglu-Besisik, Sevgi J Med Cases Case Report Extramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagnosis of MPE was confirmed by the detection of myeloma cells in the pleural fluid using flow cytometric analyses. We present a case of a 67-year-old male patient with IgG-kappa myelom. After a few line treatment regimens, he was admitted to hospital with back pain and blurred consciousness, and pleural effusion was detected. Pleural fluid analysis showed malignant plasma cells. It is a rare presentation of multiple myeloma, but important in diagnosis. Elmer Press 2020-03 2020-03-26 /pmc/articles/PMC8383523/ /pubmed/34434362 http://dx.doi.org/10.14740/jmc3428 Text en Copyright 2020, Alkan et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Alkan, Onur Tiryaki, Tarik Onur Kalayoglu-Besisik, Sevgi Myelomatous Pleural Effusion: A Rare Involvement in Myeloma |
title | Myelomatous Pleural Effusion: A Rare Involvement in Myeloma |
title_full | Myelomatous Pleural Effusion: A Rare Involvement in Myeloma |
title_fullStr | Myelomatous Pleural Effusion: A Rare Involvement in Myeloma |
title_full_unstemmed | Myelomatous Pleural Effusion: A Rare Involvement in Myeloma |
title_short | Myelomatous Pleural Effusion: A Rare Involvement in Myeloma |
title_sort | myelomatous pleural effusion: a rare involvement in myeloma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383523/ https://www.ncbi.nlm.nih.gov/pubmed/34434362 http://dx.doi.org/10.14740/jmc3428 |
work_keys_str_mv | AT alkanonur myelomatouspleuraleffusionarareinvolvementinmyeloma AT tiryakitarikonur myelomatouspleuraleffusionarareinvolvementinmyeloma AT kalayoglubesisiksevgi myelomatouspleuraleffusionarareinvolvementinmyeloma |